Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 559

1.

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW Jr, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL; Shingles Prevention Study Group.

N Engl J Med. 2005 Jun 2;352(22):2271-84.

2.

Vaccination: a new option to reduce the burden of herpes zoster.

Mick G.

Expert Rev Vaccines. 2010 Mar;9(3 Suppl):31-5. doi: 10.1586/erv.10.32. Review.

PMID:
20192716
3.

A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.

Holcomb K, Weinberg JM.

J Drugs Dermatol. 2006 Oct;5(9):863-6. Review.

PMID:
17039651
4.

Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults.

Sanford M, Keating GM.

Drugs Aging. 2010 Feb 1;27(2):159-76. doi: 10.2165/10489140-000000000-00000. Review.

PMID:
20104941
5.

Prevention strategies: herpes zoster, post-herpetic neuralgia and immunogenicity.

Levin MJ, Schmader K.

Herpes. 2007 Sep;14 Suppl 2:45-7. Review.

PMID:
17939896
6.

Zoster vaccine live (Oka/Merck).

Robinson DM, Perry CM.

Drugs Aging. 2006;23(6):525-31; discussion 532-3. Review.

PMID:
16872235
7.

Prevention of herpes zoster and its painful and debilitating complications.

Johnson R, McElhaney J, Pedalino B, Levin M.

Int J Infect Dis. 2007 Nov;11 Suppl 2:S43-8. doi: 10.1016/S1201-9712(07)60021-6. Review.

8.

Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.

Betts RF.

J Am Acad Dermatol. 2007 Dec;57(6 Suppl):S143-7.

PMID:
18021866
9.

Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Pellissier JM, Brisson M, Levin MJ.

Vaccine. 2007 Nov 28;25(49):8326-37. Epub 2007 Oct 17.

PMID:
17980938
10.

Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Hornberger J, Robertus K.

Ann Intern Med. 2006 Sep 5;145(5):317-25.

PMID:
16954357
11.

Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Rothberg MB, Virapongse A, Smith KJ.

Clin Infect Dis. 2007 May 15;44(10):1280-8. Epub 2007 Apr 3.

PMID:
17443464
12.

Vaccination against Herpes Zoster and Postherpetic Neuralgia.

Oxman MN, Levin MJ; Shingles Prevention Study Group.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S228-36. doi: 10.1086/522159.

13.

Zoster vaccine live.

Kockler DR, McCarthy MW.

Pharmacotherapy. 2007 Jul;27(7):1013-9. Review.

PMID:
17594207
14.

Vaccination to prevent herpes zoster in older adults.

Gnann JW Jr.

J Pain. 2008 Jan;9(1 Suppl 1):S31-6. doi: 10.1016/j.jpain.2007.10.007. Review.

PMID:
18166463
15.

Prevention of shingles by varicella zoster virus vaccination.

Holodniy M.

Expert Rev Vaccines. 2006 Aug;5(4):431-43. Review.

PMID:
16989624
16.

Varicella zoster vaccines.

Creed R, Satyaprakash A, Ravanfar P.

Dermatol Ther. 2009 Mar-Apr;22(2):143-9. doi: 10.1111/j.1529-8019.2009.01226.x. Review.

PMID:
19335725
17.

Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect.

Levin MJ, Barber D, Goldblatt E, Jones M, LaFleur B, Chan C, Stinson D, Zerbe GO, Hayward AR.

J Infect Dis. 1998 Nov;178 Suppl 1:S109-12.

PMID:
9852987
18.

[Herpes zoster and postherpetic neuralgia - prevention by vaccination?].

Wutzler P.

Dtsch Med Wochenschr. 2009 Apr;134 Suppl 2:S90-4. doi: 10.1055/s-0029-1220217. Epub 2009 Apr 7. German.

PMID:
19353479
19.

A novel vaccine (Zostavax) to prevent herpes zoster.

Holcomb K, Weinberg JM.

G Ital Dermatol Venereol. 2008 Apr;143(2):119-23. Review.

PMID:
18833038
20.

Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence.

Oxman MN.

J Am Osteopath Assoc. 2009 Jun;109(6 Suppl 2):S13-7. Review.

PMID:
19553630

Supplemental Content

Support Center